Detalles de la búsqueda
1.
Gilteritinib and the risk of intracranial hemorrhage: a case series of a possible, under-reported side effect.
Ann Hematol
; 102(11): 3025-3030, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37606693
2.
Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia.
Am J Hematol
; 98(11): 1711-1720, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37635400
3.
Durable Molecular Remission in an Elderly Patient Affected by Relapsed Ph'+ Acute Lymphoblastic Leukemia with T315I and Concomitant p190 and p210 Expression Achieved by Inotuzumab and Ponatinib.
Chemotherapy
; 66(3): 78-81, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34102636
4.
Identification of predictive factors for overall survival at baseline and during azacitidine treatment in high-risk myelodysplastic syndrome patients treated in the clinical practice.
Ann Hematol
; 98(8): 1919-1925, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31168652
5.
Ten-year outcome of chronic-phase chronic myeloid leukemia patients treated with imatinib in real life.
Ann Hematol
; 98(8): 1891-1904, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31079264
6.
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice.
Ann Hematol
; 98(8): 1885-1890, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31044260
7.
Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib.
Ann Hematol
; 98(4): 889-896, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30515542
8.
Maintenance therapy in AML: The past, the present and the future.
Am J Hematol
; 94(11): 1254-1265, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31429099
9.
Treatment-free remission in chronic myeloid leukemia.
Clin Adv Hematol Oncol
; 17(12): 686-696, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31851157
10.
Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events.
Ann Hematol
; 97(10): 1803-1808, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29806063
11.
Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy.
Ann Hematol
; 97(10): 1797-1802, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29951912
12.
Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse?
Eur J Haematol
; 2018 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-29896890
13.
Impact of exclusion criteria for the DASISION and ENESTnd trials in the front-line treatment of a 'real-life' patient population with chronic myeloid leukaemia.
Hematol Oncol
; 35(2): 232-236, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26648184
14.
Ruxolitinib in clinical practice for primary and secondary myelofibrosis: an analysis of safety and efficacy of Gruppo Laziale of Ph-negative MPN.
Ann Hematol
; 96(3): 387-391, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27889820
15.
New landscapes in the management of myelodysplastic syndromes and chronic myelomonocytic leukemia: oral decitabine.
Future Oncol
; 17(16): 1973-1975, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33878941
16.
SARS-CoV-2 infection anxieties and general population restrictions delay diagnosis and treatment of acute haematological malignancies.
Br J Haematol
; 190(1): e5-e8, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32369605
17.
Application of systematic coronary risk evaluation chart to identify chronic myeloid leukemia patients at risk of cardiovascular diseases during nilotinib treatment.
Ann Hematol
; 94(3): 393-7, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25304102
18.
Incidence of persistent/late chronic anemia in newly diagnosed patients with chronic myeloid leukemia responsive to imatinib.
Am J Hematol
; 90(2): 105-8, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25349084
19.
Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC).
Support Care Cancer
; 23(11): 3289-95, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25910751
20.
Negative prognostic value of CD34 antigen also if expressed on a small population of acute promyelocytic leukemia cells.
Ann Hematol
; 93(11): 1819-23, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24912771